1. Home
  2. PTIX vs LGHL Comparison

PTIX vs LGHL Comparison

Compare PTIX & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagenic Therapeutics Inc.

PTIX

Protagenic Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

LGHL

Lion Group Holding Ltd.

HOLD

Current Price

$4.26

Market Cap

3.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTIX
LGHL
Founded
1994
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.3M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
PTIX
LGHL
Price
$1.65
$4.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.8K
719.2K
Earning Date
11-26-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$3.78
52 Week High
$14.28
$213.20

Technical Indicators

Market Signals
Indicator
PTIX
LGHL
Relative Strength Index (RSI) 33.67 53.43
Support Level $1.46 $4.03
Resistance Level $1.70 $8.92
Average True Range (ATR) 0.18 1.29
MACD -0.00 -0.05
Stochastic Oscillator 20.65 45.53

Price Performance

Historical Comparison
PTIX
LGHL

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: